tiprankstipranks
Trending News
More News >
Cynata Therapeutics Limited (AU:CYP)
:CYP
Advertisement

Cynata Therapeutics Limited (CYP) Price & Analysis

Compare
7 Followers

CYP Stock Chart & Stats


Cynata Therapeutics Limited News

CYP FAQ

What was Cynata Therapeutics Limited’s price range in the past 12 months?
Cynata Therapeutics Limited lowest share price was AU$0.14 and its highest was AU$0.28 in the past 12 months.
    What is Cynata Therapeutics Limited’s market cap?
    Cynata Therapeutics Limited’s market cap is AU$39.54M.
      When is Cynata Therapeutics Limited’s upcoming earnings report date?
      Cynata Therapeutics Limited’s upcoming earnings report date is Sep 01, 2025 which is in 24 days.
        How were Cynata Therapeutics Limited’s earnings last quarter?
        Cynata Therapeutics Limited released its earnings results on Feb 27, 2025. The company reported -AU$0.02 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.02.
          Is Cynata Therapeutics Limited overvalued?
          According to Wall Street analysts Cynata Therapeutics Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Cynata Therapeutics Limited pay dividends?
            Cynata Therapeutics Limited does not currently pay dividends.
            What is Cynata Therapeutics Limited’s EPS estimate?
            Cynata Therapeutics Limited’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Cynata Therapeutics Limited have?
            Cynata Therapeutics Limited has 225,954,380 shares outstanding.
              What happened to Cynata Therapeutics Limited’s price movement after its last earnings report?
              Cynata Therapeutics Limited reported an EPS of -AU$0.02 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 13.043%.
                Which hedge fund is a major shareholder of Cynata Therapeutics Limited?
                Currently, no hedge funds are holding shares in AU:CYP

                Cynata Therapeutics Limited Stock Smart Score

                Company Description

                Cynata Therapeutics Limited

                Cynata Therapeutics Limited (CYP) is an Australian biotechnology company focused on the development and commercialization of innovative stem cell therapies. The company specializes in Cymerus™, a proprietary technology for manufacturing mesenchymal stem cells (MSCs) at scale. This platform enables the production of therapeutic stem cells without the limitation of donor availability, supporting the treatment of various diseases and medical conditions. Cynata's core products target applications in regenerative medicine, encompassing indications such as cardiovascular disease, respiratory ailments, and graft-versus-host disease (GvHD).

                Cynata Therapeutics Limited (CYP) Earnings & Revenues

                Similar Stocks
                Company
                Price & Change
                Follow
                Immutep Ltd
                Mesoblast Limited

                Ownership Overview

                0.91%99.09%
                Mutual Funds
                ― Other Institutional Investors
                99.09% Public Companies and
                Individual Investors

                Options Prices

                Currently, No data available
                ---
                Popular Stocks
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis